Ownership as of March 31, 2021. Ten largest shareholders.
| Name | Series A shares | Series B shares | Share capital % | Voting rights % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENTS AB | 377736 | 410478 | 7.02 | 28.63 |
| SIX SIS AG, W8IMY | 0 | 1186542 | 10.57 | 8.11 |
| FJÄRDE AP-FONDEN | 0 | 1120000 | 9.98 | 7.66 |
| SWEDBANK ROBUR NY TEKNIK BTI | 0 | 579172 | 5.16 | 3.96 |
| AMF AKTIEFOND SMÅBOLAG | 0 | 501585 | 4.47 | 3.43 |
| TREDJE AP-FONDEN | 0 | 438565 | 3.91 | 3 |
| UNIONEN | 0 | 322196 | 2.87 | 2.2 |
| CBNY-NORGES BANK | 0 | 302342 | 2.69 | 2.07 |
| DANGOOR, DAVID | 0 | 278421 | 2.48 | 1.9 |
| HANDELSBANKEN SVENSKA, SMABOLAGSFOND | 0 | 250000 | 2.23 | 1.71 |
| Sub-total | 377736 | 5389301 | 51.38 | 62.67 |
| Other shareholders | 0 | 5459147 | 48.62 | 37.33 |
| Total | 377736 | 10848448 | 100 | 100 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.